Revenue: The sum of all revenue fields included for a company's operating activities.
Foghorn Therapeutics Inc. (FHTX) had Revenue of $22.60M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$22.60M |
$-86.62M |
|
-- |
|
$22.60M |
|
$125.28M |
|
$-102.68M |
|
$16.06M |
|
$-86.62M |
|
$-86.62M |
|
$-86.62M |
|
$-86.62M |
|
$-86.62M |
|
$-86.62M |
|
$-102.68M |
|
$-104.18M |
|
54.90M |
|
54.90M |
|
$-1.58 |
|
$-1.58 |
|
| Balance Sheet Financials | |
$249.60M |
|
$9.96M |
|
$34.38M |
|
$283.98M |
|
$66.99M |
|
-- |
|
$262.52M |
|
$329.51M |
|
$-45.53M |
|
$-45.53M |
|
$-45.53M |
|
55.59M |
|
| Cash Flow Statement Financials | |
$-100.41M |
|
$-29.90M |
|
$105.43M |
|
$82.04M |
|
$57.16M |
|
$-24.88M |
|
$11.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-454.31% |
|
-454.31% |
|
-460.92% |
|
-383.24% |
|
-383.24% |
|
$-101.31M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
190.26% |
|
190.26% |
|
-30.50% |
|
190.26% |
|
$-0.82 |
|
$-1.85 |
|
$-1.83 |
|